Pay in 4 interest-free payments of $6.41 Learn more
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14
Orforglipron is central to Eli Lillys oral strategy
While its generally well-tolerated, there are a few rare but serious side effects that patients should be aware of
You are responsible for any customs duties or import requirements in your jurisdiction
The three receptors it targets are: GLP-1 receptors : Help control appetite and slow digestion GIP receptors : Support insulin function and glucose regulation Glucagon receptors : Promote energy expenditure and fat burning This triple-action approach sets Retatrutide apart from current FDA-approved medications, such as semaglutide (found in Ozempic and Wegovy), which only target GLP-1 receptors, and tirzepatide (Mounjaro and Zepbound), which targets both GLP-1 and GIP receptors
Research Citations Doe, J
US$ 26.23
US$ 20.55
US$ 27.02
US$ 23.74
US$ 21.39
